Centro de Investigacion Biomedica en Red de Salud Mental-ko ikertzaileekin lankidetzan egindako argitalpenak (43)

2022

  1. Eating and nutritional habits in patients with schizophrenia

    Revista de Psiquiatria y Salud Mental, Vol. 15, Núm. 1, pp. 54-60

2021

  1. Are older adults also at higher psychological risk from COVID-19?

    Aging and Mental Health, Vol. 25, Núm. 7, pp. 1297-1304

  2. Difficulties in delivery and depressive symptomatology in schizophrenia

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 1, pp. 66-68

  3. Factors associated with alcohol and tobacco consumption as a coping strategy to deal with the coronavirus disease (COVID-19) pandemic and lockdown in Spain

    Addictive Behaviors, Vol. 121

  4. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis

    Schizophrenia Research, Vol. 236, pp. 19-28

  5. Modeling psychological function in patients with schizophrenia with the PANSS: An international multi-center study

    CNS Spectrums, Vol. 26, Núm. 3, pp. 290-298

  6. Real-World Functioning in Patients With Schizophrenia: Beyond Negative and Cognitive Symptoms

    Frontiers in Psychiatry, Vol. 12

2020

  1. COVID-19 lockdown in people with severe mental disorders in Spain: Do they have a specific psychological reaction compared with other mental disorders and healthy controls?

    Schizophrenia Research, Vol. 223, pp. 192-198

  2. Cognitive impairment and C-reactive protein in clinically stable schizophrenia outpatients: a focus on sex differences

    Scientific Reports, Vol. 10, Núm. 1

  3. Early Psychological Correlates Associated With COVID-19 in A Spanish Older Adult Sample

    American Journal of Geriatric Psychiatry, Vol. 28, Núm. 12, pp. 1287-1298

  4. Early psychological impact of the 2019 coronavirus disease (COVID-19) pandemic and lockdown in a large Spanish sample

    Journal of global health, Vol. 10, Núm. 2, pp. 020505

  5. Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort

    Acta Psychiatrica Scandinavica, Vol. 141, Núm. 6, pp. 541-552

  6. Prevalence of Passive Suicidal Ideation in the Early Stage of the Coronavirus Disease 2019 (COVID-19) Pandemic and Lockdown in a Large Spanish Sample

    The Journal of clinical psychiatry, Vol. 81, Núm. 6

  7. Smoking cessation improves clinical outcome in severe mental disorders and is modulated by genetic variability at CHRNA5 gene

    Schizophrenia Research

2019

  1. "readiness to Change" Predicts Efficacy of Reduction among Smokers with Severe Mental Illness

    European Addiction Research, Vol. 25, Núm. 5, pp. 256-262

  2. Breadth and depth of working memory and executive function compromises in mild cognitive impairment and their relationships to frontal lobe morphometry and functional competence

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 11, pp. 170-179

  3. Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia?

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 9-16

  4. Consumo de cannabis y alteraciones cognitivas en esquizofrenia y primeros episodios psicóticos

    Adicciones: Revista de socidrogalcohol, Vol. 31, Núm. 2, pp. 89-94

  5. Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis

    European Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 786-794

  6. History of Lifetime Cannabis Use Is Associated with Better Cognition and Worse Real-World Functioning in Schizophrenia Spectrum Disorders

    European Addiction Research, Vol. 25, Núm. 3, pp. 111-118